|
ESPL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.417000000001E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5296199999959E-05 |
| Normal-vs-Stage2 |
2.24659999999988E-05 |
| Normal-vs-Stage3 |
7.398000E-03 |
| Normal-vs-Stage4 |
1.622180E-02 |
| Stage1-vs-Stage2 |
7.496600E-01 |
| Stage1-vs-Stage3 |
2.383800E-03 |
| Stage1-vs-Stage4 |
3.649800E-02 |
| Stage2-vs-Stage3 |
1.170200E-02 |
| Stage2-vs-Stage4 |
2.851600E-02 |
| Stage3-vs-Stage4 |
9.880000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16750000000743E-05 |
| Normal-vs-AfricanAmerican |
3.53770000000031E-05 |
| Normal-vs-Asian |
2.844400E-03 |
| Caucasian-vs-AfricanAmerican |
6.914200E-01 |
| Caucasian-vs-Asian |
6.026800E-01 |
| AfricanAmerican-vs-Asian |
3.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81655000000003E-05 |
| Normal-vs-Female |
5.824200E-04 |
| Male-vs-Female |
2.042200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.985700E-04 |
| Normal-vs-Extreme_Weight |
4.58029999994558E-06 |
| Normal-vs-Obese |
8.33370000000722E-05 |
| Normal-vs-Extreme_Obese |
1.22120000001225E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.845830E-01 |
| Normal_Weight-vs-Obese |
7.007600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.877600E-02 |
| Extreme_Weight-vs-Obese |
4.391700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.089810E-01 |
| Obese-vs-Extreme_Obese |
2.635300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.757870E-02 |
| Normal-vs-Age(41-60Yrs) |
7.94179999999978E-05 |
| Normal-vs-Age(61-80Yrs) |
1.80864000000058E-05 |
| Normal-vs-Age(81-100Yrs) |
1.571800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.778000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.421900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.735800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.207000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.802400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.615200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.7123999999954E-06 |
| Normal-VS-Type2 PRCC |
4.556900E-04 |
| Normal-VS-KIRP CIMP |
5.140400E-01 |
| Normal-VS-Unclassified PRCC |
3.64969999999687E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.615500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.99181999999132E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.316600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.416400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.033500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.081100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.804900000008E-05 |
| Normal-vs-N1 |
9.496300E-02 |
| Normal-vs-N2 |
4.848600E-01 |
| N0-vs-N1 |
1.982070E-03 |
| N0-vs-N2 |
5.702300E-02 |
| N1-vs-N2 |
9.985000E-01 |
|
|
